Atlas Trials

Study of Bortezomib Combined With ACVBP in Peripheral T-cell Lymphoma

Clinical trial NCT00136565 · COMPLETED

Trial details

NCT number
NCT00136565
Sponsor
Lymphoma Study Association
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Peripheral T-cell Lymphoma
Start date
2006-01-08
Primary completion
2011-04-18
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.